Fecal transplant for recurrent clostridium difficile infection in children with and without inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 5, 2014, Pages 588-592

  Russell, George H ^a   Kaplan, Jess L ^a   Youngster, Ilan ^b   Baril Dore, Mariah ^a   Schindelar, Lili ^a   Hohmann, Elizabeth ^a   Winter, Harland S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Crohn disease; fecal microbiome transplant; inflammatory bowel disease; recurrent Clostridium difficile infection; ulcerative colitis

Indexed keywords

ADALIMUMAB; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NITAZOXANIDE; PENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOATING; CELLULITIS; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; CONSTIPATION; CORTICOSTEROID THERAPY; CROHN DISEASE; DIARRHEA; ENZYME IMMUNOASSAY; FECAL MICROBIOME TRANSPLANTATION; FECES; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFLAMMATORY BOWEL DISEASE; INFUSION; LOOSE FECES; MALE; MICROBIOME; NASOGASTRIC TUBE; ORGAN TRANSPLANTATION; PATIENT SAFETY; PHYSICIAN GLOBAL ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; RECTUM HEMORRHAGE; RECURRENT CLOSTRIDIUM DIFFICILE INFECTION; RECURRENT INFECTION; SCHOOL CHILD; SCREENING TEST; TREATMENT OUTCOME; ULCERATIVE COLITIS; CASE REPORT; CLOSTRIDIUM INFECTIONS; COMPLICATION; DIGESTIVE TRACT INTUBATION; DRUG EFFECTS; MICROBIOLOGY; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; PROCEDURES; RECURRENT DISEASE; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLONOSCOPY; FECES; FEMALE; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; INTUBATION, GASTROINTESTINAL; MALE; MICROBIOTA; RECURRENCE; TRANSPLANTATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900297692     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000283     Document Type: Article

References (35)

1. Pepin J. Improving the treatment of Clostridium difficile-associated disease: where should we start? Clin Infect Dis 2006;43:553-5.
2. Khanna S, Baddour LM, Huskins WC, et al. The epidemiology of Clostridium difficile infection: a population based study. Clin Infect Dis 2013;56:1401-6.
3. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769-75.
4. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008;197:435-8.
5. Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958;44:854-9.
6. Brandt L, Reddy S. Fecal microbiota transplant for recurrent Clostridium difficile infection. J Clin Gastroenterol 2011;45 (suppl):S159-67.
7. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003;36:580-5.
8. Borody TJ. "Flora power"-fecal bacteria cure chronic C. difficile diarrhea. Am J Gastreonterol 2000;95:3028-9.
9. van Nood E, Speelman P, Kuijper EJ, et al. Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill 2009;14:ii:19316.
10. Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 2010;44:567-70.
11. Garborg K, Waagsb B, Stallemo A, et al. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhea. Scand J Infect Dis 2010;42:857-61.
12. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53:994-1002.
13. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368: 407-15.
14. Bakken J, Borody T, Brandt L, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011;9:1044-9.
15. Improve Care Now Collaborative. PGA definitions. https://improvecar-enow. org/care-providers/pga-definitions. Accessed December 11, 2013.
16. Russell G, Kaplan J, Ferraro M, et al. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 2010;126:e239-42.
17. Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk: four states. MMWR Morb Mortal Wkly Rep 2005;54:1201-5.
18. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010;16:604-9.
19. Backhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science 2005;307:1915-20.
20. Dethlefsen L, Huse S, Sogin ML, et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6:e280.
21. Yang F, Polk DB. Commensal bacteria in the gut: learning who our friends are. Curr Opin Gastoenterol 2004;20:565-71.
22. Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human feces with age and with Clostridium difficile infection. J Med Microbiol 2002;51:448-54.
23. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Micro-biol 2009;7:526-36.
24. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 2009;136:2015-31.
25. Kassam Z, Lee CH, Yuan Y, et al. Fecal microbiota transplant for Clostridium difficile infection: systemic review and meta-analysis. Am J Gastroenterol 2013;108:500-8.
26. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010;44:551-61.
27. Khoruts A, Sadowsky MJ. Therapeutic transplantation of the distal gut microbiotia. Mucosal Immunol 2011;4:4-7.
28. Gustafsson A, Lund-Tonnesen S, Berstad A, et al. Fecal short chain fatty acids in patients with antibiotic-associated diarrhea, before and after fecal enema treatment. Scand J Gastroenterol 1998;33:721-7.
29. Gustafsson A, Berstad A, Lund-Tonnesen S, et al. The effect of fecal enema on five microflora-associated characteristics in patients with antibiotics associated diarrhea. Scand J Gastroenterol 1999;34:580-6.
30. Anderson JL, Edny RJ, Whelan K. Systematic review: faecal microbiota transplant in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012;36:503-16.
31. Borody TJ, Warren EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003;37:42-7.
32. Kunde S, Pham A, Bonczyck S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013;56:597-601.
33. Reddy SS, Brandt LJ. Clostridium difficile infection and inflammatory bowel disease. J Clin Gastroenterol 2013;47:666-71.
34. Mir SA, Kellermayer R. Clostridium difficile infection in newly diagnosed pediatric inflammatory bowel disease in the mid-southern United States. J Pediatr Gastroenterol Nutr 2013;57:487-8.
35. Kump PK, Grochenig HP, Lackner S, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013;19:2155-65.